Article

Five Ways to Reduce Your Risk of Breast and Ovarian Cancer

Author(s):

Bright Pink

Women begin accumulating risk and establishing their lifestyle behaviors when they are young. What many don’t realize is that they have the power to be advocates for their health by reducing their risk or detecting these diseases at early, non-life-threatening stages.

Bright Pink, a national nonprofit focused on the prevention and early detection of breast and ovarian cancer, outlines 5 actions that young women can take to influence their relative risk of breast and ovarian cancer.

Related Videos
Image of woman.
Image of woman.
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Image of man with grey hair.
Related Content
Ovaries.
March 31st 2025

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

Spencer Feldman
The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illustration of woman with grey hair.
March 26th 2025

Surviving Scans While Surviving Breast Cancer

Felicia Mitchell
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
Illustration of ovaries.
March 24th 2025

First Patient Dosed in Phase 3 Trial of IBI354 for Ovarian Cancer

Spencer Feldman
The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.